LA VALUTAZIONE DEL RISCHIO CHIRURGICO. Paolo Caraceni

Size: px
Start display at page:

Download "LA VALUTAZIONE DEL RISCHIO CHIRURGICO. Paolo Caraceni"

Transcription

1 MONOTEMATICA AISF 2014 Cirrosi epatica: Napoli 10 anni dopo. Napoli, 8-10 Ottobre 2014 LA VALUTAZIONE DEL RISCHIO CHIRURGICO Paolo Caraceni Dipartimento di Scienze Mediche e Chirurgiche Centro di Ricerca Biomedica Applicata (CRBA) Alma Mater Studiorum Università di Bologna

2 Prof. Paolo Caraceni Alma Mater Studiorum Università di Bologna Il sottoscritto dichiara di non aver avuto negli ultimi 12 mesi conflitto d interesse in relazione a questa presentazione e che la presentazione non contiene discussione di farmaci in studio o ad uso off-label

3 CLINICAL SCENARIO 68 years old, Child B8, transient jaundice, gallbladder stones Refraining elective surgery Perform colecistectomy Obstructive jaundice Cholangitis What will kill this patient first: cirrhosis or stones? Which is the risk related to each choice? Acute on Chronic Liver Failure Emergent surgery/endoscopy? (higher risk)

4 CAN LITERATURE HELP US? YES.. BUT WITH MANY LIMITATIONS Most retrospective studies Rare randomized clinical trials Small sample size Selected populations (mostly Child-Pugh A and low MELD) Low-level evidences

5 PATIENT TYPE OF SURGERY PREDICTION OF RISK OF MORTALITY AND MORBIDITY AFTER NON-HEPATIC SURGERY EXPERTISE OF THE SURGICAL AND MEDICAL TEAM

6 PATIENT PREDICTION OF RISK OF MORTALITY AND MORBIDITY AFTER NON-HEPATIC SURGERY

7 SURGICAL RISK IN CIRRHOTIC PATIENTS PATIENT S VARIABLES LIVER DISEASE SEVERITY CO-MORBIDITIES AGE

8 CHRONIC LIVER DISEASE NATURAL HISTORY ASYMPTOMATIC PHASE SYMPTOMATIC PHASE HBV ETOH PORTAL HYPERTENSION CIRCULATORY DYSFUNCTION PRO-INFLAMMATORY STATE NASH HCV OTHERS jaundice ascites variceal bleeding hepatic encephalopathy bacterial infection HCC OLT DEATH CHRONIC HEPATITIS COMPENSATED CIRRHOSIS DECOMPENSATED CIRRHOSIS

9 PROGNOSTIC SCORES IN CIRRHOSIS CHILD-PUGH MELD MELD-BASED INDICES

10 PREDICTION OF SURGICAL RISK IN CIRRHOSIS CHILD-PUGH SCORE 100 POST-OPERATIVE MORTALITY (%) A B C Child-Pugh class De Goede et al., Best Pract Res Clin Gastroenterol, 2012

11 PREDICTION OF SURGICAL RISK IN CIRRHOSIS CHILD-PUGH SCORE 100 POST-OPERATIVE MORBIDITY (%) A B C Child-Pugh class Telem et al., Clin Gastroenterol Hepatol, 2010

12 PREDICTION OF SURGICAL RISK IN CIRRHOSIS MELD SCORE RELATIONSHIP BETWEEN MELD AND POST-OPERATIVE MORTALITY 30 days 90 days Teh et al., Gastroenterology, 2007

13 PREDICTION OF SURGICAL RISK IN CIRRHOSIS MELD SCORE POST-OPERATIVE MORBIDITY (%) <10 10 to to 25 >25 MELD SCORE Telem et al., Clin Gastroenterol Hepatol, 2010

14 PREDICTION OF SURGICAL RISK IN CIRRHOSIS EFFECT OF PORTAL HYPERTENSION A NATIONWIDE COHORT STUDY - ELECTIVE SURGERY IN-HOSPITAL MORTALITY Controls (n= ) Cirrhosis (n=18.335) Cirrhosis with portal hypertension (n=4214) Csikesz et al., Am Coll Surg, 2008

15 PREDICTION OF SURGICAL RISK IN CIRRHOSIS PATIENT VARIABLES INFLUENCING OUTCOME American Society of Anesthesiology, 2010 hyponatremia (< 130 meq/l) low serum albumin (< mg/dl) serum creatinine serum bilirubin ascites etiology of cirrhosis older age ASA score > 2-3..

16 SURGICAL RISK IN CIRRHOSIS SEARCHING FOR A PREDICTION MODEL 772 patients with cirrhosis 426 consecutive patients: consecutive patients: Major surgery 586 patients: digestive (laparatomy) 107 patients: orthopedic 79 patients: cardiovascular Comparison with two control groups 562 cirrhotics seen as outpatients 303 cirrhotics undergone minor surgery (appendicectomy, herniorrhaphy, ) Teh et al., Gastroenterology, 2007

17 SURGICAL RISK IN CIRRHOSIS SEARCHING FOR A PREDICTION MODEL 3 months 1 year 3 years Teh et al., Gastroenterology, 2007

18 SURGICAL RISK IN CIRRHOSIS SEARCHING FOR A PREDICTION MODEL DETERMINANTS OF POSTOPERATIVE MORTALITY AT MULTIVARIATE ANALYSIS MELD SCORE (liver disease severity) ASA SCORE (co-morbidities) AGE Teh et al., Gastroenterology, 2007

19 SURGICAL RISK IN CIRRHOSIS MAYO CLINIC POSTOPERATIVE MORTALITY RISK MODEL Google: surgical risk cirrhosis

20 SURGICAL RISK IN CIRRHOSIS MAYO CLINIC POSTOPERATIVE MORTALITY RISK MODEL MELD day mortality: 6% 3-fold increase Google: surgical risk cirrhosis

21 SURGICAL RISK IN CIRRHOSIS MAYO CLINIC POSTOPERATIVE MORTALITY RISK MODEL LIMITATIONS OF THE STUDY Retrospective Selection bias: sicker patients deferred Most patients had platelet > / L and INR < 1.5 Only 58 out of 772 patients had MELD > 15 Most surgical procedures were intra-abdominal

22 SURGICAL RISK IN CIRRHOSIS RISK ACCORDING TO PATIENT VARIABLES CHILD A no portal hypertension CHILD A with portal hypertension CHILD B CHILD C MELD < 8/10 MELD 8/10 16/18 MELD > 16/18 POST-OPERATIVE MORTALITY RISK MODEL MAYO CLINIC

23 PATIENT TYPE OF SURGERY PREDICTION OF RISK OF MORTALITY AND MORBIDITY AFTER NON-HEPATIC SURGERY

24 PREDICTION OF SURGICAL RISK IN CIRRHOSIS UMBILICAL HERNIA REPAIR A NATIONWIDE COHORT STUDY ( controls vs cirrhotic patients) Carbonell et al, Hernia, 2005

25 PREDICTION OF SURGICAL RISK IN CIRRHOSIS LAPAROSCOPIC COLECISTECTOMY META-ANALYSIS (351 cirrhotic patients) Puggioni and Wong, Liv Intern, J Am Coll Surg 2003

26 PREDICTION OF SURGICAL RISK IN CIRRHOSIS COLORECTAL SURGERY A NATIONWIDE COHORT STUDY ( controls vs cirrhotics without PH vs cirrhotics with PH) Control Cirrhosis without PH Cirrhosis with PH 35,8 Mortality (%) ,6 20, ,1 7,2 1,8 All Elective Non-elective Nguyen et al, Dis Colon Rectum, 2009

27 PREDICTION OF SURGICAL RISK IN CIRRHOSIS CARDIAC SURGERY REVIEW OF THE LITERATURE MORTALITY RISK Modi et al, Inter Cardiovascul Thorac Surg 2010

28 PREDICTION OF SURGICAL RISK IN CIRRHOSIS TYPE OF SURGERY Umbilical and inguinal hernia repair Colorectal surgery Gastrectomy Pancreatic surgery Cardiac surgery Laparoscopic colecistectomy Open colecistectomy Lung surgery Abdominal trauma Orthopedic surgery Laparoscopic Laparotomic Elective Emergency

29 SURGICAL RISK IN CIRRHOSIS RISK ACCORDING TO TYPE OF ELECTIVE SURGERY LOW INTERMEDIATE HIGH UNACCEPTABLE or UKNOWN Abdominal wall surgery CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Laparoscopic colecistectomy CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Open abdomen surgery CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Lung surgery CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Orthopedic surgery CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Cardiac surgery CHILD A - no PTH CHILD A - PTH CHILD B - off pump CHILD B - on pump CHILD C

30 PATIENT TYPE OF SURGERY PREDICTION OF RISK OF MORTALITY AND MORBIDITY AFTER NON-HEPATIC SURGERY EXPERTISE OF THE SURGICAL AND MEDICAL TEAM

31 PREDICTION OF SURGICAL RISK IN CIRRHOSIS HOW TO MINIMIZE RISK Availaibility of less invasive approaches: laparoscopic techniques mini-invasive surgical techniques interventional radiology operative endoscopy Specific surgical expertise with cirrhotic patients MULTIDISCIPLINARY APPROACH High skill surgeon Specific medical expertise in the management of the pre-, peri-, and post-operative periods with cirrhotic patients

32 GRAZIE PER L ATTENZIONE

Coinfezione HIV-HCV. Raffaele Bruno, MD. Department of Infectious Diseases, University of Pavia Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Coinfezione HIV-HCV. Raffaele Bruno, MD. Department of Infectious Diseases, University of Pavia Fondazione IRCCS Policlinico San Matteo, Pavia, Italy Coinfezione HIV-HCV Raffaele Bruno, MD This program is supported by educational grants from Department of Infectious Diseases, University of Pavia Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

More information

Francesco Vizzutti. Azienda Ospedaliero Universitaria Careggi, Firenze

Francesco Vizzutti. Azienda Ospedaliero Universitaria Careggi, Firenze Francesco Vizzutti Azienda Ospedaliero Universitaria Careggi, Firenze Il sottoscritto dichiara di non aver avuto negli ultimi dodici mesi conflitto d interesse in relazione a questa presentazione e che

More information

Evaluation and Prognosis of Patients with Cirrhosis

Evaluation and Prognosis of Patients with Cirrhosis Evaluation and Prognosis of Patients with Cirrhosis Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded

More information

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco

More information

Acute on Chronic Liver Failure: Current Concepts. Disclosures

Acute on Chronic Liver Failure: Current Concepts. Disclosures Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures

More information

Assessing the risk of surgery in patients with liver disease

Assessing the risk of surgery in patients with liver disease REVIEW CME CREDIT AMITABH SUMAN, MD VA Medical Center and Shands Hospital at University of Florida, Gainesville WILLIAM D. CAREY, MD Director, Center for Continuing Education; Department of Gastroenterology,

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function

More information

Cirrhosis and HCV. Jonathan Israel M.D.

Cirrhosis and HCV. Jonathan Israel M.D. Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment

More information

HOW TO MANAGE A PATIENT ON SYSTEMIC CHEMOTHERAPY

HOW TO MANAGE A PATIENT ON SYSTEMIC CHEMOTHERAPY 15th AISF PRE-MEETING COURSE Treatment of hepatocellular carcinoma Rome, February 20th HOW TO MANAGE A PATIENT ON SYSTEMIC CHEMOTHERAPY Dott. Massimo Iavarone 1 Division of Gastroenterology Fondazione

More information

A 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation.

A 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation. A 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation. Three years ago he was treated with 24 weeks of peginterferon alfa-2a (180 µg/wk, PEGIFN)

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV

Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV Universitätsklinikum Leipzig Thomas Berg Sektion Hepatologie Klinik und Poliklinik für Gastroenterologie und Rheumatologie Leber- und Studienzentrum

More information

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto PREVENTION OF HCC BY HEPATITIS C TREATMENT Morris Sherman University of Toronto Pathogenesis of HCC in chronic hepatitis C Injury cirrhosis HCC Injury cirrhosis HCC Time The Ideal Study Prospective randomized

More information

End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012

End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012 End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012 Natural History of ESLD Increasing liver fibrosis Development of HCC Chronic liver disease Compensated cirrhosis Decompensated cirrhosis

More information

Approach to Abnormal Liver Tests

Approach to Abnormal Liver Tests Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School

More information

Guide to Abdominal or Gastroenterological Surgery Claims

Guide to Abdominal or Gastroenterological Surgery Claims What are the steps towards abdominal surgery? Investigation and Diagnosis It is very important that all necessary tests are undertaken to investigate the patient s symptoms appropriately and an accurate

More information

The following should be current within the past 6 months:

The following should be current within the past 6 months: EVALUATION Baseline Labs Obtain at time or prior to initial evaluation CBC with diff PT/INR CMP HCV Genotype (obtained PRIOR TO consult visit) HCV RNA (obtained PRIOR TO consult visit) Hep A IgG Hep BsAg,

More information

Assessment of risk for non-hepatic surgery in cirrhotic patients

Assessment of risk for non-hepatic surgery in cirrhotic patients Assessment of risk for non-hepatic in cirrhotic patients Prashant Bhangui 1, Alexis Laurent 2, Roland Amathieu 3, Daniel Azoulay 4, 1 Medanta Institute of Liver Transplantation and Regenerative Medicine,

More information

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common

More information

PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS

PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS As a patient you must be adequately informed about your condition and the recommended surgical procedure. Please read this document carefully and ask about anything you do not understand. Please initial

More information

BURDEN OF LIVER DISEASE IN BRAZIL

BURDEN OF LIVER DISEASE IN BRAZIL BURDEN OF LIVER DISEASE IN BRAZIL Burden of Liver Disease in Europe Blachier et al. J Hepatol 58:593, 2013 Review of 260 epidemiologic studies of the 5 previous years Cirrhosis is responsible for 170.000

More information

Appendix G - Identification and Selection of Studies

Appendix G - Identification and Selection of Studies FINAL Emergency framework for rationing of blood for massively bleeding patients during a red phase of a Appendix G - Identification and Selection of Studies Inclusion/Exclusion Criteria We included studies

More information

Original Article Laparoscopic Cholecystectomy Pak Armed Forces Med J 2015; 65(2): 252-56

Original Article Laparoscopic Cholecystectomy Pak Armed Forces Med J 2015; 65(2): 252-56 Original Article Laparoscopic Cholecystectomy Pak Armed Forces Med J 2015; 65(2): 252-56 LAPAROSCOPIC CHOLECYSTECTOMY: A CLINICAL PRACTICE AUDIT Mannan Masud, Maqbool Ahmed*, Zafar Iqbal Gondal, Muhammad

More information

The State of the Liver in the Adult Patient after Fontan Palliation

The State of the Liver in the Adult Patient after Fontan Palliation The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital

More information

Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents

Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents Introduction... 2 Specialty Excellence Award Determination... 3 America s 100 Best Hospitals

More information

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok Management of hepatitis C: pre- and post-liver transplantation Piyawat Komolmit Bangkok Liver transplantation and CHC Cirrhosis secondary to HCV is the leading cause of liver transplantation in the US

More information

Optimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado

Optimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado Optimal Management of Splenic/Portal Vein Thrombosis David Mauchley University of Colorado Overview Portal Vein Thrombosis (PVT) Etiology Presentation/Clinical Aspects Diagnosis Management Cirrhotic vs.

More information

Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives

Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives Medical Knowledge and Patient Care: Residents must demonstrate knowledge and application of the pathophysiology and epidemiology

More information

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease From : New England Journal of Medicine Volume 351:1521-1531, Number 15, Oct 7, 2004 馬 偕 紀 念 醫 院 一 般 內 科, 肝 膽 腸 胃 科 新 竹 分 院 陳 重

More information

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient

More information

UCLA Asian Liver Program

UCLA Asian Liver Program CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,

More information

Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC) Abhishek Vadalia Introduction Chemoembolization is being used with increasing frequency in the treatment of solid hepatic tumors such as Hepatocellular Carinoma (HCC) & rare Cholangiocellular Carcinoma

More information

HEPATOCELLULAR CARCINOMA (HCC) RESECTION VERSUS TRANSPLANTATION. Francis Yao, M.D.

HEPATOCELLULAR CARCINOMA (HCC) RESECTION VERSUS TRANSPLANTATION. Francis Yao, M.D. UCSF TRANSPLANT CONFERENCE - 9/28/2012 HEPATOCELLULAR CARCINOMA (HCC) RESECTION VERSUS TRANSPLANTATION Francis Yao, M.D. Professor of Clinical Medicine and Surgery Medical Director, Liver Transplantation

More information

Leading the Way to Treat Liver Cancer

Leading the Way to Treat Liver Cancer Leading the Way to Treat Liver Cancer Guest Expert: Sukru, MD Professor of Transplant Surgery Mario Strazzabosco, MD Professor of Internal Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale

More information

The most serious symptoms of this stage are:

The most serious symptoms of this stage are: The Natural Progression of Hepatitis C The natural history of hepatitis C looks at the likely outcomes for people infected with the virus if there is no medical intervention. However, the process of trying

More information

Endoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy. M. Arvanitakis SRBG June 2009

Endoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy. M. Arvanitakis SRBG June 2009 Endoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy M. Arvanitakis SRBG June 2009 Outline Antibiotic prophylaxis during endoscopy Upper GI endoscopy Lower

More information

LIVER TRANSPLANTATION IN ALAGILLE SYNDROME

LIVER TRANSPLANTATION IN ALAGILLE SYNDROME LIVER TRANSPLANTATION IN ALAGILLE SYNDROME Ronald J. Sokol, MD Children s Hospital Colorado University of Colorado School of Medicine Treatment of Liver Disease in Improve bile flow ALGS Ursodeoxycholic

More information

Surgery in the Patient with Liver Disease

Surgery in the Patient with Liver Disease Surgery in the Patient with Liver Disease Jacqueline G. O Leary, MD, MPH a, Patrick S.Yachimski, MD, MPH b,c,d, Lawrence S. Friedman, MD e,f,g,h, * KEYWORDS Cirrhosis Surgery MELD score Child class Liver

More information

Approach to Abnormal Liver Tests

Approach to Abnormal Liver Tests This Morning s Presentation Approach to Abnormal Liver Tests Hal F. Yee, Jr., M.D., Ph.D. Rice Distinguished Professor, UCSF Chief of Gastroenterology, SFGH hyee@medsfgh.ucsf.edu Clinical vignettes representing

More information

Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy. Patient Name

Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy. Patient Name Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy Patient Name Please read this form carefully and ask about anything you may not understand. I consent to have a laparoscopic Vertical Sleeve

More information

Alcoholic Hepatitis (Teacher s Guide)

Alcoholic Hepatitis (Teacher s Guide) Thomas Ormiston, M.D. Updated 5/5/15 2007-2015, SCVMC Alcoholic Hepatitis (Teacher s Guide) (30 minutes) I. Objectives Recognize the signs and symptoms of alcoholic hepatitis Understand the treatment options

More information

Colocutaneous Fistula. Disclosures

Colocutaneous Fistula. Disclosures Colocutaneous Fistula Madhulika G. Varma MD Associate Professor Chief, Colorectal Surgery University of California, San Francisco Honoraria Applied Medical Covidien Disclosures 1 Colocutaneous Fistula

More information

Recommendations 8/14/2014. Hepatitis C Clinical Approach Primary Care. Purpose of Presentation. HCV Prevalence Year of Birth

Recommendations 8/14/2014. Hepatitis C Clinical Approach Primary Care. Purpose of Presentation. HCV Prevalence Year of Birth Hepatitis C Clinical Approach Primary Care Dr. Vicki L. MIt McIntyre, FNP Tucson Gastroenterology Specialists Tucson, Arizona University of Phoenix Lead Faculty, Department of Nursing Tucson, Arizona Purpose

More information

Characterisation of co-morbidities in patients with alcoholic liver disease and engaging them in treatment.

Characterisation of co-morbidities in patients with alcoholic liver disease and engaging them in treatment. Characterisation of co-morbidities in patients with alcoholic liver disease and engaging them in treatment. Khairunnessa Rahman, Dheeraj Shukla, Leigh Dahlenburg, Andrew Bailey, Robert Gribble, Paul Haber

More information

Cirrhosis of liver: Etiological factors, complications and prognosis

Cirrhosis of liver: Etiological factors, complications and prognosis Original Article Cirrhosis of liver: Etiological factors, complications and prognosis Suhail Ahmed Almani, A. Sattar Memon, Amir Iqbal Memon, M. Iqbal Shah, M. Qasim Rahpoto, Rahim Solangi ABSTRACT OBJECTIVE:

More information

Chapter 6 Gastrointestinal Impairment

Chapter 6 Gastrointestinal Impairment Chapter 6 Gastrointestinal This chapter consists of 2 parts: Part 6.1 Diseases of the digestive system Part 6.2 Abdominal wall hernias and obesity PART 6.1: DISEASES OF THE DIGESTIVE SYSTEM Diseases of

More information

National Health Burden of CLD in Italy

National Health Burden of CLD in Italy National Health Burden of CLD in Italy 11,000 deaths due to liver cirrhosis or HCC in 2006 Direct costs for the National Health System for treating CLD patients: 420 M / year for hospital care 164 M /

More information

EBM DELL ERNIA OMBELICALE

EBM DELL ERNIA OMBELICALE U.O. Chirurgia Generale Ospedale Campostaggia Poggibonsi Primario Dott. Alessandro BIANCHI EBM DELL ERNIA OMBELICALE Dott. Massimo RANALLI It is unwise to be too sure of one s own wisdom. It is healthy

More information

Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs

Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Last update: February 23, 2015 Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Please see healthpartners.com for Medicare coverage criteria. Table of Contents 1. Harvoni 2. Sovaldi

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic

What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic Introduction Elevated liver enzymes is often not a clinical problem by itself. However it is a warning

More information

HCV/HIVCo-infection A case study by. Dominic Côté, Nurse Clinician B.Sc Chronic Viral Illness Services McGill University Health Centre

HCV/HIVCo-infection A case study by. Dominic Côté, Nurse Clinician B.Sc Chronic Viral Illness Services McGill University Health Centre HCV/HIVCo-infection A case study by Dominic Côté, Nurse Clinician B.Sc Chronic Viral Illness Services McGill University Health Centre Objectives By sharing a case study of a patient co-infected with HIV/HCV

More information

LIVER FUNCTION TESTS AND STATINS

LIVER FUNCTION TESTS AND STATINS LIVER FUNCTION TESTS AND STATINS Philippe J. Zamor and Mark W. Russo Current Opinion in Cardiology 2011,26:338 341 SUMMARY Purpose of review: To discuss recent data on statins in patients with elevated

More information

C A R O L I N A S. Hernia Handbook ( C H A P T E R 2 ) B. Todd Heniford, MD

C A R O L I N A S. Hernia Handbook ( C H A P T E R 2 ) B. Todd Heniford, MD C A R O L I N A S Hernia Handbook ( C H A P T E R 2 ) B. Todd Heniford, MD C H A P T E R 2 Umbilical Hernias C A R O L I N A S H E R N I A H A N D B O O K 17 Umbilical Hernias W H AT I S A N U M B I L

More information

MANAGEMENT OF LIVER CIRRHOSIS

MANAGEMENT OF LIVER CIRRHOSIS MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different

More information

Laparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions

Laparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions Laparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions What are the Colon and Rectum? The colon and rectum together make up the large intestine. After

More information

Liver, Gallbladder and Pancreas diseases. Premed 2 Pathophysiology

Liver, Gallbladder and Pancreas diseases. Premed 2 Pathophysiology Liver, Gallbladder and Pancreas diseases Premed 2 Pathophysiology Pancreas Pancreatitis Acute Pancreatitis Autodigestion of the pancreas due to activation of the enzymes Hemorrhagic fat necrosis, calcium

More information

Bile Duct Diseases and Problems

Bile Duct Diseases and Problems Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.

More information

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis Research Article Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis RR. Pawar*, ML. Pardeshi and BB. Ghongane Department of Pharmacology, B.J. Medical

More information

Laparoscopic Gallbladder Removal (Cholecystectomy) Patient Information from SAGES

Laparoscopic Gallbladder Removal (Cholecystectomy) Patient Information from SAGES Laparoscopic Gallbladder Removal (Cholecystectomy) Patient Information from SAGES Gallbladder removal is one of the most commonly performed surgical procedures. Gallbladder removal surgery is usually performed

More information

SURGICAL PREAMBLE SPECIFIC ELEMENTS SURGICAL SERVICES WHICH ARE NOT LISTED AS A "Z" CODE

SURGICAL PREAMBLE SPECIFIC ELEMENTS SURGICAL SERVICES WHICH ARE NOT LISTED AS A Z CODE Surgical PreambleApril 1, 2015 PREAMBLE SPECIFIC ELEMENTS In addition to the common elements, all surgical services include the following specific elements. A. Supervising the preparation of and/or preparing

More information

Preoperative drainage is always indicated in malignant CBD strictures PRO. Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany

Preoperative drainage is always indicated in malignant CBD strictures PRO. Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany Preoperative drainage is always indicated in malignant CBD strictures PRO Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany Background Jaundice is associated with high perioperative morbidity

More information

Bariatric i Surgery: Optimalizing Outcome Results. Dr. B. Dillemans AZ Sint-Jan AV Brugge-Oostende BARIATRIC SURGERY

Bariatric i Surgery: Optimalizing Outcome Results. Dr. B. Dillemans AZ Sint-Jan AV Brugge-Oostende BARIATRIC SURGERY Bariatric i Surgery: Optimalizing i Outcome Results Dr. B. Dillemans AZ Sint-Jan AV Brugge-Oostende THE OBESE PATIENT : A CHALLENGE FOR ANAESTHESIA, Ostend,14/11/09 BARIATRIC SURGERY 50 s : First Reported

More information

Surgical Site Infection Prevention

Surgical Site Infection Prevention Surgical Site Infection Prevention 1 Objectives 1. Discuss risk factors for SSI 2. Describe evidence-based best practices for SSI prevention 3. State principles of antibiotic prophylaxis 4. Discuss novel

More information

Bariatric Surgery: What the Internist Needs to Know

Bariatric Surgery: What the Internist Needs to Know Bariatric Surgery: What the Internist Needs to Know Richard Stahl, MD, FACS Assistant Professor of Surgery Medical Director of Bariatric Surgery Disclosures None (sadly) Objectives Describe several myths

More information

Obesity Affects Quality of Life

Obesity Affects Quality of Life Obesity Obesity is a serious health epidemic. Obesity is a condition characterized by excessive body fat, genetic and environmental factors. Obesity increases the likelihood of certain diseases and other

More information

Ledipasvir/Sofosbuvir (Harvoni) for Treatment of Hepatitis C

Ledipasvir/Sofosbuvir (Harvoni) for Treatment of Hepatitis C Ledipasvir/Sofosbuvir (Harvoni) for Treatment of Hepatitis C Policy Number: Original Effective Date: MM.04.034 12/1/2014 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 12/1/2014

More information

The digestive system. Medicine and technology. Normal structure and function Diagnostic methods Example diseases and therapies

The digestive system. Medicine and technology. Normal structure and function Diagnostic methods Example diseases and therapies The digestive system Medicine and technology Normal structure and function Diagnostic methods Example diseases and therapies The digestive system An overview (1) Oesophagus Liver (hepar) Biliary system

More information

Hepatocellular Carcinoma: What the hepatologist wants to know

Hepatocellular Carcinoma: What the hepatologist wants to know Hepatocellular Carcinoma: What the hepatologist wants to know Hélène Castel, MD Liver Unit Hôpital St-Luc CHUM? CAR Annual Scientific Meeting Saturday, April 27 th 2013 Disclosure statement I do not have

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT

PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT HARVONI (90mg ledipasvir/400mg sofosbuvir): tablet (PREFERRED AGENT) SOVALDI (sofosbuvir ): 400mg tablets (PREFERRED AGENT ) OLYSIO (simeprivir) PEG-INTRON

More information

Clinical Case n. 3 Massimo Puoti AO Ospedale Niguarda Ca Granda Milano, Italy

Clinical Case n. 3 Massimo Puoti AO Ospedale Niguarda Ca Granda Milano, Italy Clinical Case n. 3 Massimo Puoti AO Ospedale Niguarda Ca Granda Milano, Italy Disclosures Member of advisory boards &/or speaker in own events &/or investigator in RCT &/or research grants &/or teacher

More information

Transmission of HCV in the United States (CDC estimate)

Transmission of HCV in the United States (CDC estimate) Transmission of HCV in the United States (CDC estimate) Past and Future US Incidence and Prevalence of HCV Infection Decline among IDUs Overall incidence Overall prevalence Infected 20+ years Armstrong

More information

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis Measure #401: Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School

More information

Elective versus emergency surgery for ulcerative colitis: a National Surgical Quality Improvement Program analysis

Elective versus emergency surgery for ulcerative colitis: a National Surgical Quality Improvement Program analysis The American Journal of Surgery (2013) 205, 333-338 Midwest Surgical Association Elective versus emergency surgery for ulcerative colitis: a National Surgical Quality Improvement Program analysis Supriya

More information

Facing a Hernia Repair? Learn about minimally invasive da Vinci Surgery

Facing a Hernia Repair? Learn about minimally invasive da Vinci Surgery Facing a Hernia Repair? Learn about minimally invasive da Vinci Surgery The Condition: Hernia A hernia happens when part of an internal organ or tissue bulges through a hole or weak area in the belly wall

More information

INFORMED CONSENT FOR SLEEVE GASTRECTOMY

INFORMED CONSENT FOR SLEEVE GASTRECTOMY INFORMED CONSENT FOR SLEEVE GASTRECTOMY This informed-consent document has been prepared to help inform you about your Sleeve Gastrectomy including the risks and benefits, as well as alternative treatments.

More information

Specific Standards of Accreditation for Residency Programs in General Surgery

Specific Standards of Accreditation for Residency Programs in General Surgery Specific Standards of Accreditation for Residency Programs in General Surgery 2010 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation of the

More information

Abnormal Liver Function. Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London

Abnormal Liver Function. Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London Abnormal Liver Function Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London Does Liver Disease Matter? Mortality in England & Wales Liver-related

More information

Bowel Preparation for Colon Resection. Eric Klein, M.D. SUNY Downstate Department of Surgery

Bowel Preparation for Colon Resection. Eric Klein, M.D. SUNY Downstate Department of Surgery Bowel Preparation for Colon Resection Eric Klein, M.D. SUNY Downstate Department of Surgery Historical Perspective During World War II, failure to treat penetrating colon injuries with diversion could

More information

What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon

What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon "it looks like there's something wrong.with your television set. Matt Groenig, creator of The Simpsons Probability of an abnormal screening

More information

ELSO GUIDELINES FOR ECMO CENTERS

ELSO GUIDELINES FOR ECMO CENTERS ELSO GUIDELINES FOR ECMO CENTERS PURPOSE These guidelines developed by the Extracorporeal Life Support Organization, outline the ideal institutional requirements needed for effective use of extracorporeal

More information

HEPATOLOGY CLERKSHIP

HEPATOLOGY CLERKSHIP College of Osteopathic Medicine HEPATOLOGY CLERKSHIP Office for Clinical Affairs 515-271-1629 FAX 515-271-1727 Elective Rotation General Description This elective rotation is a four (4) week introductory,

More information

AASLD PRACTICE GUIDELINE AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation

AASLD PRACTICE GUIDELINE AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation AASLD PRACTICE GUIDELINE AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation Karen F. Murray and Robert L. Carithers, Jr. Preamble These recommendations provide a data-supported

More information

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.

More information

Overview of Bariatric Surgery

Overview of Bariatric Surgery Overview of Bariatric Surgery To better understand how weight loss surgery works, it is helpful to know how the normal digestive process works. As food moves along the digestive tract, special digestive

More information

Perspective End-Stage Liver Disease in HIV Disease

Perspective End-Stage Liver Disease in HIV Disease Perspective End-Stage Liver Disease in HIV Disease Liver disease is the most common non AIDS-related cause of mortality in HIV-infected patients. HIV-infected patients with chronic liver disease progress

More information

EMR Decision Tool. Clinical and functional elements for EMR software

EMR Decision Tool. Clinical and functional elements for EMR software EMR Decision Tool Clinical and functional elements for EMR software AGA Institute EMR Clinical and Functional Elements EMR Decision Tool To assist gastroenterologists in the decision process needed to

More information

The Natural History of Hepatitis C Cirrhosis After Liver Transplantation

The Natural History of Hepatitis C Cirrhosis After Liver Transplantation LIVER TRANSPLANTATION 15:1063-1071, 2009 ORIGINAL ARTICLE The Natural History of Hepatitis C Cirrhosis After Liver Transplantation Roberto J. Firpi,* Virginia Clark,* Consuelo Soldevila-Pico, Giuseppe

More information

INFORMATION SHEET FOR A LAPAROSCOPIC SLEEVE GASTRECTOMY

INFORMATION SHEET FOR A LAPAROSCOPIC SLEEVE GASTRECTOMY INFORMATION SHEET FOR A LAPAROSCOPIC SLEEVE GASTRECTOMY You are considering undergoing a laparoscopic sleeve gastrectomy for weight loss. The purpose of this information sheet is to provide you with the

More information

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

BACKGROUND MEDIA INFORMATION Fast facts about liver disease BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of

More information

23/06/2014. Nutrition in Chronic Liver Disease. Objectives. Question #1

23/06/2014. Nutrition in Chronic Liver Disease. Objectives. Question #1 Nutrition in Chronic Liver Disease Maitreyi Raman, MD, FRCPC Clinical Associate Professor University of Calgary April 2014 Objectives 1. Describe contributing factors toward malnutrition in advanced liver

More information

Machine learning of patient similarity: a case study on predicting survival in cancer patient after locoregional chemotherapy.

Machine learning of patient similarity: a case study on predicting survival in cancer patient after locoregional chemotherapy. Title Machine learning of patient similarity: a case study on predicting survival in cancer patient after locoregional chemotherapy Author(s) Chan, LWC; Chan, T; Cheng, LF; Mak, WS Citation The 2010 IEEE

More information

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing

More information

Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011

Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011 Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call March 16, 2011 Case Presentations Kansas City Free Health Clinic Carilion Clinic Didactic Session Challenges in Determining HCV Treatment

More information

Clinical Practice Assessment Robotic surgery

Clinical Practice Assessment Robotic surgery Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through

More information

Dr Alessandro Armuzzi, UOC di Medicina Interna e Gastroenterologia Complesso Integrato Columbus Università Cattolica

Dr Alessandro Armuzzi, UOC di Medicina Interna e Gastroenterologia Complesso Integrato Columbus Università Cattolica Dr Alessandro Armuzzi, UOC di Medicina Interna e Gastroenterologia Complesso Integrato Columbus Università Cattolica Il sottoscritto dichiara di non aver avuto negli ultimi 12 mesi conflitto d interesse

More information